Researchers from the Vanderbilt University School of Medicine in Nashville, Tenn., compared the risk of death among patients on long-acting opioid therapy for chronic pain with that of patients on analgesic anticonvulsant or low-dose cyclic antidepressant treatments.
They found patients on opioids had a risk of all-cause mortality that was 1.6 times greater than the mortality of the control group patients. More than two-thirds of the deaths were not related to unintentional overdose; and more than half of those deaths were cardiovascular deaths.
“These findings should be considered when evaluating harms and benefits of treatment,” the authors wrote.
More articles on opioids:
Senate panel approves $261M funding bill to fight opioid epidemic
5 states where opioid overdose antidote prices rose the most
AHA, CDC create new patient resource on prescription opioids
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.